Portfolio 2 Investments
Tubulis
biotechnology, oncology, antibody-drug conjugates, healthcare
series-c
€308 M
Oct 2025
Investor
Quantum Systems
defense, drones, aerospace
series-d
$1.2 B
Jul 2026
Investor